Skip to content
★ Sign in to follow
KM

Kaitlyn Melanie Arsenault

Chief Financial Officer
Skye Bioscience, Inc.
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 16 Dec 2021 for Skye Bioscience, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Kaitlyn Melanie Arsenault: trading record in brief

One trade, one date: on 16 December 2021, Kaitlyn Melanie Arsenault disclosed a share grant in Skye Bioscience, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kaitlyn Melanie Arsenault

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration